NexGel (NXGL) Competitors $2.42 -0.10 (-3.78%) As of 02:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. APYX, GUTS, NVNO, MDAI, NSPR, SRTS, ZYXI, CTSO, HYPR, and SURGShould you be buying NexGel stock or one of its competitors? The main competitors of NexGel include Apyx Medical (APYX), Fractyl Health (GUTS), enVVeno Medical (NVNO), Spectral AI (MDAI), InspireMD (NSPR), Sensus Healthcare (SRTS), Zynex (ZYXI), Cytosorbents (CTSO), Hyperfine (HYPR), and SurgePays (SURG). These companies are all part of the "medical equipment" industry. NexGel vs. Its Competitors Apyx Medical Fractyl Health enVVeno Medical Spectral AI InspireMD Sensus Healthcare Zynex Cytosorbents Hyperfine SurgePays Apyx Medical (NASDAQ:APYX) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment. Do analysts recommend APYX or NXGL? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67NexGel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, APYX or NXGL? Apyx Medical has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Comparatively, NexGel has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Which has preferable earnings and valuation, APYX or NXGL? NexGel has lower revenue, but higher earnings than Apyx Medical. NexGel is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApyx Medical$48.10M1.60-$23.46M-$0.55-3.70NexGel$8.69M2.13-$3.28M-$0.45-5.37 Is APYX or NXGL more profitable? NexGel has a net margin of -30.80% compared to Apyx Medical's net margin of -42.37%. NexGel's return on equity of -54.95% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Apyx Medical-42.37% -156.85% -31.92% NexGel -30.80%-54.95%-27.84% Does the media favor APYX or NXGL? In the previous week, NexGel had 1 more articles in the media than Apyx Medical. MarketBeat recorded 2 mentions for NexGel and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.87 beat NexGel's score of 0.94 indicating that Apyx Medical is being referred to more favorably in the media. Company Overall Sentiment Apyx Medical Very Positive NexGel Positive Do institutionals and insiders have more ownership in APYX or NXGL? 55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 15.2% of Apyx Medical shares are held by insiders. Comparatively, 20.6% of NexGel shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryNexGel beats Apyx Medical on 8 of the 15 factors compared between the two stocks. Get NexGel News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNexGelMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.48M$6.67B$5.56B$9.30BDividend YieldN/A1.20%4.23%4.03%P/E Ratio-5.3725.5628.6319.67Price / Sales2.1390.00439.23185.66Price / CashN/A20.3636.0257.93Price / Book2.684.658.185.64Net Income-$3.28M$174.76M$3.23B$257.73M7 Day Performance-11.21%-1.46%-0.20%0.21%1 Month Performance-6.03%0.96%5.43%8.47%1 Year Performance14.45%2.90%26.39%13.93% NexGel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNexGel0.7069 of 5 stars$2.42-3.8%N/A+17.3%$18.48M$8.69M-5.3710Gap UpAPYXApyx Medical2.2004 of 5 stars$2.03+3.2%N/A+49.6%$76.87M$48.10M-3.70270Positive NewsGUTSFractyl Health2.4554 of 5 stars$1.52-3.2%$11.00+623.7%-66.9%$74.69M$90K-0.82102NVNOenVVeno Medical0.6335 of 5 stars$4.16-3.0%N/A-33.3%$72.97MN/A-3.5330Positive NewsMDAISpectral AI3.5408 of 5 stars$2.85+6.2%$4.75+67.0%+51.9%$72.16M$29.58M-5.2883NSPRInspireMD2.773 of 5 stars$2.30-2.3%$4.50+96.0%-5.3%$70.46M$7.03M-3.0750SRTSSensus Healthcare1.0546 of 5 stars$4.27-1.3%$11.67+173.5%-30.3%$70.43M$41.81M42.8440ZYXIZynex2.0389 of 5 stars$2.20+4.0%$6.00+173.3%-75.7%$66.35M$192.35M-9.14770Upcoming EarningsAnalyst ForecastCTSOCytosorbents1.5472 of 5 stars$1.03-1.9%$5.50+434.0%-3.7%$64.49M$35.33M-3.68220HYPRHyperfine3.1386 of 5 stars$0.79-1.4%$1.06+34.3%-24.1%$61.41M$11.73M-1.46190Positive NewsSURGSurgePays3.1672 of 5 stars$2.94-1.5%$9.00+205.7%-3.3%$60.09M$40.03M-1.0640 Related Companies and Tools Related Companies APYX Alternatives GUTS Alternatives NVNO Alternatives MDAI Alternatives NSPR Alternatives SRTS Alternatives ZYXI Alternatives CTSO Alternatives HYPR Alternatives SURG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexGel, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexGel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.